Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial
Mice develop obesity and lose myocardial metabolic flexibility months after exertional heat stroke
& Park, F
It has become well understood that technology pushsimply funding the development of advanced technologiesis not in and of itself sufficient to lead to the adoption of technologies downstream
doi: 10.3389/fonc.2025.1570288 Received 03 February 2025 Accepted 11 March 2025 Published 11 April 2025 Volume 15 - 2025 Edited by Alvaro Marn Hernndez, Instituto Nacional de Cardiologa, Mexico Reviewed by Qingkai Xue, Jiangsu Institute of Parasitic Diseases (JIPD), China Jean Pierre Ndabakuranye, RMIT University, Australia Yang Zhou, Hainan University, China Updates Copyright 2025 Yi, Tao and Wu